AML Insights – July-August Update: What’s New in the Field

Uncover the latest insights in acute myeloid leukemia – from novel immunotherapy targets like IGSF9 and CD84, to innovative treatment approaches such as vaccine-primed T cells, TLR2 agonism, and refined use of venetoclax. Explore how genomic profiling of extramedullary AML and updated relapse prognostic models are transforming diagnosis and disease management.
Don’t miss these exciting developments!